- UCLA researcher receives prestigious grant to advance understanding of treatment-resistant melanoma
The Melanoma Research Alliance Foundation has awarded a $900,000 grant for research led by Dr. Roger Lo, a member of the UCLA Jonsson Comprehensive Cancer Center, to advance the understanding of mechanisms that determine response and resistance to two of the most promising therapies for advanced melanoma, the deadliest form of skin cancer.
May 06, 2016 6:00 AMdetail
- UCLA Jonsson Cancer Center Foundation’s 21st Annual Taste for a Cure raises nearly $1 million for cancer research
The UCLA Jonsson Cancer Center Foundation hosted their premiere annual benefit, Taste for a Cure on Thursday April 28th at the Beverly Wilshire Hotel. Five hundred people attended the sold out fundraiser, helping to raise almost $1 million dollars at night’s end. BMW was the presenting sponsor.
May 04, 2016 11:00 AMdetail
- Dr. Antoni Ribas receives American Association for Cancer Research award
UCLA’s Dr. Antoni Ribas has received the Richard and Hinda Rosenthal Memorial Award from the American Association for Cancer Research. The award honors investigators relatively early in their careers whose research has made, or promises to soon make, a notable contribution to improved clinical care in the field of cancer.
May 02, 2016 9:00 AMdetail
- Widely used chemotherapy does not lead to cognitive decline for women with breast cancer, UCLA study finds
A new study by UCLA researchers has found that a commonly used chemotherapy drug shows no association with cognitive decline following treatment in women with breast cancer. The report addresses recent concerns that the specific use of anthracycline-based therapies can lead to decreased neuropsychological functioning and cognitive difficulties, such as memory loss.
April 21, 2016 9:00 AMdetail
- Immunotherapy drug shows long-lasting response in advanced melanoma, UCLA study finds
UCLA researchers have found that a game-changing immunotherapy drug produces positive responses that are long-lasting and with less side effects than traditional treatments in people with advanced melanoma, the deadliest and most aggressive form skin cancer.
April 20, 2016 10:30 AMdetail
- UCLA research in understanding treatment-resistant melanoma listed among AACR’s most-cited of 2014
Groundbreaking research into a promising new class of drugs called BRAF inhibitors led by UCLA Jonsson Comprehensive Cancer Center member Dr. Roger Lo has been selected by the American Association for Cancer Research (AACR) for inclusion in “The Best of AACR Journals 2014,” the organization’s annual review highlighting its journals’ most highly cited and influential studies of the year.
April 17, 2016 9:00 AMdetail
- Experimental therapy for brain cancer developed by UCLA and Caltech could prevent drug resistance
UCLA and Caltech researchers have developed a technique that shows promise for preventing drug resistance in people with glioblastoma, the most common and deadliest type of brain cancer.
April 14, 2016 11:00 AMdetail
- UCLA joins collaboration to advance cancer immunotherapy research
Already a national leader in cancer immunotherapy, UCLA has joined forces with five of the nation’s other top cancer centers to form the Parker Institute for Cancer Immunotherapy. The consortium’s aim is to maximize the potential of cancer immunotherapy research.
April 12, 2016 10:30 PMdetail
- UCLA scientists pioneer new method to identify brain cancer patients most likely to benefit from immunotherapy
UCLA researchers have developed a promising method to assess how changes in the immune response can help predict the effectiveness of a new immunotherapy in people with glioblastoma (GBM), the most common and deadly type of brain cancer.
April 04, 2016 1:00 PMdetail
- UCLA researcher advances PET imaging technology to improve patient's response to cancer treatment
A promising new discovery by UCLA scientists could lead to a new method of identifying cancer patients that express high levels of an enzyme and are more likely to respond to cancer treatments.
March 28, 2016 12:00 PMdetail
- UCLA study uncovers key new insights into how cells are wired to survive radiation therapy
A UCLA-led study has for the first time shown that microRNAs, specifically the microRNA known as miR-34, can sit silently in an inactive state in a cell waiting for a signal to turn it on.
March 21, 2016 6:00 AMdetail
- Research funded to study cancer and the immune system
With new funding awarded by the California Institute for Regenerative Medicine, Dr. Lili Yang hopes to engineer the body’s immune system to give it the ability to attack and kill cancerous cells, while leaving the body’s healthy tissues unharmed.
March 18, 2016 10:00 AMdetail
- UCLA study identifies factors that shape how advanced melanoma responds to immunotherapy
A new study by UCLA researchers has revealed how patterns of gene mutations and expression in a melanoma tumor before starting anti-PD-1 immunotherapy may forecast whether the tumor would shrink or the patient would derive survival benefits.
March 17, 2016 9:00 AMdetail
- New method of drug delivery may be safer and more effective against pancreatic cancer
UCLA scientists have developed a delivery system for one chemotherapy drug that greatly reduces the occurrence of serious side effects while enhancing the drug’s effectiveness against pancreatic cancer.
March 02, 2016 10:30 AMdetail